Benzalink 24 Injection contains Benzathine Penicillin G 2,400,000 IU, a long-acting injectable antibiotic designed to provide prolonged antibacterial coverage. This high-dose formulation is used in the treatment of serious bacterial infections, including syphilis, streptococcal infections, and for the prevention of rheumatic fever. Its extended-release profile ensures effective therapy over weeks with a single injection.
The injection delivers consistent therapeutic levels, allowing healthcare providers to manage infections efficiently while reducing the number of doses required. Its potent bactericidal action is highly effective against Gram-positive bacteria, making it ideal for clinical use in hospitals, primary care settings, and community healthcare programs.
For distributors and suppliers, Benzalink 24 Injection represents a high-demand, essential antibiotic with continuous prescription needs. Its long-acting nature makes it particularly attractive to pharmacies, government institutions, and healthcare centers seeking reliable, fast-moving injectable medicines. Stocking it ensures steady sales and recurring demand throughout the year.
Including Benzalink 24 Injection in your product portfolio strengthens your position in the anti-infective and antibiotic segment, providing opportunities for bulk supply, institutional contracts, export, and third-party manufacturing partnerships. Its essential status, high clinical value, and long-acting properties make it a profitable and strategic addition for any pharmaceutical supplier or distributor.